Study on Lenvatinib and Pembrolizumab for Treating Worsening Anal or Rectum Cancer After Initial Treatment | Clinical Trial

Study on Lenvatinib and Pembrolizumab for Treating Worsening Anal or Rectum Cancer After Initial Treatment | Clinical Trial | Right2Hope